CTI BioPharma Corp.

CTI BioPharma Corp.

Sector: Medical Laboratories Region: WA, United States

: | Berlin Stock Exchange: CEPR | Nasdaq: CTIC | Milan Stock Exchange: CTIC

Similar to: EpiStem Holdings Plc

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, OPAXIO, Brostallicin and Bisplatinates. Pixuvri is a novel anthracycline derivative used for the treatment of hematologic malignancies and solid tumors. The company was founded by James A. Bianco, Jack W. Singer and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

News & Analysis

You may also be interested in: